RHODE ISLAND HOSPITAL, left, and Butler Hospital are recruiting participants for the AHEAD Study, a global clinical trial looking into the efficacy of the drug lecanemab for individuals at high risk of developing symptoms of Alzheimer’s disease. / COURTESY RHODE ISLAND HOSPITAL AND BUTER HOSPITAL
PROVIDENCE – Two Rhode Island hospitals are recruiting participants for a clinical trial to test the effect of lecanemab in treating preclinical Alzheimer’s disease. Butler Hospital’s Memory and Aging Program and Rhode Island Hospital’s Alzheimer’s Disease and Memory Disorders Center are recruiting individuals who are at high risk of developing Alzheimer’s disease for the AHEAD…
Want to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.
